InnoCare Pharma Limited announces that Mr. Shan Fu ("Mr. Fu") has resigned as a non-executive Director with effect from 27 March 2023 immediately after the closure of the Board meeting held on the same day, due to his primary business commitments at Vivo Capital LLC requiring more of his dedication and time commitment, where he has served as a joint chief executive officer and the Greater China chief executive officer since October 2013. Mr. Fu has confirmed that he has no disagreement with the Board and there are no matters in respect of his resignation that need to be brought to the attention of the shareholders of the Company or The Stock Exchange of Hong Kong
Limited.